1. Home
  2. NAN vs EOLS Comparison

NAN vs EOLS Comparison

Compare NAN & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Quality Municipal Income Fund

NAN

Nuveen New York Quality Municipal Income Fund

HOLD

Current Price

$11.59

Market Cap

355.4M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.61

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAN
EOLS
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.4M
407.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
NAN
EOLS
Price
$11.59
$6.61
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$15.50
AVG Volume (30 Days)
63.2K
699.7K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
4.37%
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
N/A
$13.27
Revenue Next Year
N/A
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$10.79
$3.86
52 Week High
$11.67
$10.20

Technical Indicators

Market Signals
Indicator
NAN
EOLS
Relative Strength Index (RSI) 62.79 55.74
Support Level $11.34 $6.44
Resistance Level $11.60 $7.20
Average True Range (ATR) 0.09 0.36
MACD 0.01 -0.03
Stochastic Oscillator 86.96 64.76

Price Performance

Historical Comparison
NAN
EOLS

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: